← Eichor
Condition: Malignant Hyperthermia Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Malignant Hyperthermia

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756Screening of Malignant Hyperthermia Susceptible Individuals
Phase N/A · 1 location(s) · Peking University Third Hospital · NCT05402839Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Pancreatic Cancer and Peritoneal Metastasis
Phase 2 · 1 location(s) · Mayo Clinic · NCT04858009Robotic Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Treatment of Gastric Cancer With Limited Periton
Phase 2 · 1 location(s) · Mayo Clinic · NCT05753306A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma
Phase 2 · 13 location(s) · Memorial Sloan Kettering Cancer Center · NCT06057935Telehealth Intervention for Improving Distress and Financial Toxicity in the Caregivers
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06709404Registry Trial to Evaluate the Safety and Efficacy of Hyperthermia in Locally Advanced Cancers
Phase N/A · 1 location(s) · Mahatma Gandhi Institute of Medical Sciences · NCT05099809
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.